PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the world’s leading platform for outsourced research and development (R&D) services, announced a partnership with Likarda to offer online access to its innovative 3D compound screening and assay development services to scientists around the globe.
Likarda is a Kansas City-based contract research organization (CRO) and a leading provider of drug discovery and development services, primarily using 3D cell-based assaying technologies and microencapsulation. The company’s mission is to combine comprehensive early-phase discovery research with consultative and analytical services so that those in the drug discovery process can move forward confidently, efficiently, and affordably.
“We focus on bringing to market disruptive technologies that improve healthcare outcomes and lower costs for pets and people alike. To illustrate, our proprietary three-dimensional cell culture system serves as a predictive model to demonstrate how test drug compounds work in the human body. Partnering with Science Exchange gives its global client base the fastest path to our novel technologies and services,” stated Karthik Ramachandran, Ph.D., Likarda’s vice president and co-founder.
“We are excited to team up with Likarda to make its drug screening and assay development services accessible to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is committed to adding the most innovative and qualified service providers to our platform, so scientists can securely and readily access the services they need to aid their discoveries. Likarda met our rigorous standards for quality and compliance while demonstrating breakthrough discoveries in the field of 3D cell-based assaying technologies and microencapsulation.”
Founded in 2012, Likarda LLC is a world-class, cutting-edge biotech research laboratory for science entrepreneurs, pharmaceutical and nutraceutical companies, animal health, and contract research organizations (CRO). We focus on bringing to market disruptive technologies that improve health-care outcomes and lower costs for pets and people alike. Visit www.likarda.com for more information. Follow the CRO on Twitter @likardallc.
About Science Exchange
Science Exchange is the world's leading and most secure platform for outsourced research, providing large R&D organizations with the fastest path from discovery through development and commercialization. Science Exchange includes an efficient source-to-secure platform for ordering 6,000+ services from a network of more than 2,500 qualified outsourced research providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. The platform increases access to innovation and improves productivity, freeing scientists from administrative tasks and delays associated with sourcing, establishing and managing service provider contracts. Additionally, the Science Exchange enterprise program enables large R&D organizations to consolidate research outsourcing spend into a single strategic relationship, driving efficiency, improving transparency and oversight, and delivering cost savings. Since being founded in 2011, Science Exchange has raised more than $58 million from Norwest Venture Partners, Maverick Capital Ventures, Union Square Ventures, Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and others. For more information, visit www.ScienceExchange.com. Follow the company on Twitter @ScienceExchange.